Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine
NCT06613659 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1016
Last updated 2024-09-26
Summary
This is a multicenter, prospective cohort study, with syndrome differentiation and treatment of traditional Chinese medicine as the exposure factor. Patients using syndrome differentiation of traditional Chinese medicine combined with conventional treatment of Western medicine are classified as the treatment cohort of Integrated Chinese and Western medicine, and patients using conventional treatment of Western medicine only are classified as the treatment cohort of Western medicine
Conditions
- Community-Acquired Infections
Interventions
- DRUG
-
traditional Chinese medicine (TCM)
Taking the use of traditional Chinese medicine syndrome differentiation treatment as the exposure factor, the continuous use of traditional Chinese medicine for 3-5 days was defined as mild exposure, continuous use of traditional Chinese medicine for 6-10 days as moderate exposure, and continuous use of traditional Chinese medicine for more than 10 days as severe exposure. The exposed group used TCM syndrome differentiation therapy combined with conventional western medicine treatment (integrative medicine treatment cohort), and the non exposed group used conventional western medicine treatment without standardized TCM syndrome differentiation treatment (Western medicine treatment cohort). The treatment plan was formulated by the clinician, and the researcher did not intervene.
- DRUG
-
non traditional Chinese medicine (non-TCM)
Taking the use of traditional Chinese medicine syndrome differentiation treatment as the exposure factor, the continuous use of traditional Chinese medicine for 3-5 days was defined as mild exposure, continuous use of traditional Chinese medicine for 6-10 days as moderate exposure, and continuous use of traditional Chinese medicine for more than 10 days as severe exposure. The exposed group used TCM syndrome differentiation therapy combined with conventional western medicine treatment (integrative medicine treatment cohort), and the non exposed group used conventional western medicine treatment without standardized TCM syndrome differentiation treatment (Western medicine treatment cohort). The treatment plan was formulated by the clinician, and the researcher did not intervene.
Sponsors & Collaborators
-
Henan University of Traditional Chinese Medicine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-20
- Primary Completion
- 2027-04-30
- Completion
- 2027-10-30
Countries
- China
Study Locations
More Related Trials
-
TCM for Coal Worker's Pneumoconiosis
NCT04841200 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness Study of Integrative Treatment for Pediatric Community Acquired Pneumonia
NCT02362906 ·Status: UNKNOWN ·Phase: NA
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
NCT01486186 ·Status: UNKNOWN ·Phase: PHASE2
-
Idiopathic Pulmonary Fibrosis Cohort of TCM
NCT07162870 ·Status: NOT_YET_RECRUITING
-
Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection
NCT05672498 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness Study of Integrative Treatment for Pediatric Pneumonia
NCT02069665 ·Status: COMPLETED ·Phase: NA
-
Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection
NCT04251871 ·Status: UNKNOWN ·Phase: NA
-
Study on the Correlation Between TCM Syndrome, Inflammatory Phenotype and Biomarker of Bronchial Asthma
NCT04128111 ·Status: UNKNOWN
-
Acupuncture as an Adjunctive Therapy for Covid-19 Omicron Randomised Controlled Trial in Patients With Moderate/Severe Pneumonia
NCT05692258 ·Status: UNKNOWN ·Phase: NA
-
A Study on Integrated Chinese and Western Medicine for Severe Pneumonia Caused by Multidrug-Resistant Gram-Negative Bacterial Infections
NCT07206745 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Practical RCT of TCM in the Treatment of LCOVID and Analysis of Syndrome Types and Medication Characteristics.
NCT06095258 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effects of Traditional Chinese Medicine on Outcomes in Patients With AECOPD Risk Window
NCT04851093 ·Status: UNKNOWN ·Phase: NA
-
TCM as an Adjuvant Treatment in Mycobacterium Abscessus Pulmonary Disease
NCT07295938 ·Status: RECRUITING ·Phase: PHASE2
-
The Study of CCTM and Common Diseases
NCT02998944 ·Status: COMPLETED
-
A Multicenter Observational Study of an Integrated Traditional Chinese and Western Medicine Care Model in Post-Acute Treatment of Frail Elderly Patients
NCT07136935 ·Status: RECRUITING ·Phase: NA
-
Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials
NCT03147443 ·Status: UNKNOWN ·Phase: PHASE4
-
REspiratory diSEAse cohoRt Studies of CHinese Medicine for ILD (RESEARCH-ILD)
NCT06577753 ·Status: RECRUITING
-
Traditional Chinese Medicine for Treatment of Chronic Heart Failure
NCT01939236 ·Status: COMPLETED ·Phase: PHASE2
-
Traditional Chinese Medicine or Low-dose Dexamethasone in COVID-19 Pneumonia
NCT05798195 ·Status: UNKNOWN ·Phase: NA
-
Prospective Cohort of Integrated Traditional Chinese and Western Medicine in China
NCT07196917 ·Status: NOT_YET_RECRUITING
-
Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD
NCT06455670 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Building a Traditional Chinese Medicine Clinical Diagnosis and Treatment Database
NCT06525025 ·Status: NOT_YET_RECRUITING
-
The Dampness Syndrome of Chinese Medicine Cohort Study
NCT05315895 ·Status: RECRUITING
-
Real-world Clinical Study and Medical Machine Intelligence Study for Traditional Chinese Internal Medicine
NCT03274908 ·Status: UNKNOWN
-
TCM Differentiation and Treatment Protocol of COVID-19
NCT04306497 ·Status: COMPLETED